Explore
Premium
Sign Up
Log In
CRT 2017: ATHEROSCLEROSIS, PHYSIOLOGY AND IMAGING - Atherosclerosis & Lipid Management
Conference
Add this Moment to your Passport
Learn from this moment and keep it forever.
Add To Passport
$15.99
This moment is included in Simple Premium - Get started for free.
FREE
with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments.
$30.00 per month. Cancel anytime.
Overview
ATHEROSCLEROSIS, PHYSIOLOGY AND IMAGING - Atherosclerosis & Lipid Management
Featuring
Michael Davidson
Michael Lipinski
Ori Ben-Yehuda
H. Bryan Brewer
A. Michael Lincoff
Evan Stein
Add this Moment to your Passport
Learn from this moment and keep it forever.
Add To Passport
$15.99
This moment is included in Simple Premium - Get started for free.
FREE
with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments.
$30.00 per month. Cancel anytime.
Moment Components
Where are the Guidelines Going and Should We Forget the HDL Story/CETP Inhibition? - Michael Davidson
PCSK9 Inhibitors: Review of the Clinical Trials - Why Are We So Excited? - Steven Nissen
Do PCSK9 Inhibitors Cause Cognitive Impairment? - Michael Lipinski
Cardiotoxicity of Tyrosine Kinase Inhibitors: Novel Mechanisms and Implications for Atherosclerosis - Ori Ben-Yehuda
Lipoprotein(a): Genes, Biological Role, Predictive Value and Drug Interventions - Evan Stein
Update on HDL Infusions and Atherosclerosis Regression in the ACS Patient - H. Bryan Brewer
Achieving Lipid Targets with PCSK9 Inhibition: Is Lower Always Better? - Michael Lipinski
Prospects for CV Risk Factor Reduction with PCSK9 and CETP Inhibitor Therapies - A. Michael Lincoff
Are the PCSK9 Inhibitors the Panacea of Atherosclerosis Treatment? Effects on Lipid Lowering and Beyond - Evan Stein
Update on Clinical Trials With Novel CETP Inhibitors to Raise HDL: Where Are We Today? - H. Bryan Brewer
Target Audience
Cardiologists
Interventional Cardiologists
Interventional Fellows
Interventional Radiologists
Vascular Surgeons
Physicians with an interest in Cardiovascular Innovations
Learning Objectives
Related Moments
CRT 2017 : Japan FDA - Introduction of HBD Activities
Conference
CardioAlex 2016 - Intervention in Congenital Heart Disease
Conference
CardioAlex 2016 session on Intervention in Congenital Heart Disease
CVC 2016 Venous - Superficial Venous Disease IV
Conference
A session on Superficial Venous Disease IV from CVC 2016
Loading Simple Education